{"id":"2551cc02-8442-4c32-a406-f6acd2a592e9","slug":"jnj-acquires-auris-2019","acquirerCompanyId":"766676f2-56d0-4910-81dc-03703d6c9c40","acquiredCompanyId":"df69ac5c-53c1-4fa6-94d2-8f377e9bf87c","acquirerName":null,"acquiredName":"Auris Health","announcementDate":null,"closeDate":"2019-04-01T12:00:00.000Z","status":"completed","structure":"full_acquisition","valuationUsd":"3400000000","valuationBasis":"contingent","summary":"Johnson & Johnson acquired Auris Health (~$3.4B upfront plus up to $2.35B in milestones, 2019), the Monarch endoluminal platform founded by Frederic Moll (cross-ref people-graph frederic-moll). Contingent (milestone) consideration.","sources":[{"url":"https://www.jnj.com/","title":"J&J acquires Auris Health","sourceName":"Johnson & Johnson (official)"}],"verificationPosture":"verified","reviewStatus":"reviewed","createdAt":"2026-06-05T02:31:18.332Z","updatedAt":"2026-07-14T21:34:53.985Z","acquirerCompany":{"id":"766676f2-56d0-4910-81dc-03703d6c9c40","slug":"johnson-and-johnson","name":"Johnson & Johnson"},"acquiredCompany":{"id":"df69ac5c-53c1-4fa6-94d2-8f377e9bf87c","slug":"auris-health","name":"Auris Health"},"assets":[]}